MeSH tree: A15.145.229.637
Researchers at the University of Illinois Chicago have identified a molecular switch that helps determine whether cancer cells remain soft and difficult to destroy or become stiff enough for the immune system to attack.
Jul 21, 2026
0
68
Researchers from the University of Minnesota Medical School have identified why pancreatic cancer is difficult for the immune system to recognize and attack, paving the way for a new approach to improve immunotherapy. The ...
Jul 21, 2026
0
14
When the BBC presenter Lauren Laverne revealed she has smoldering myeloma, the diagnosis sounded more alarming than it is. Her situation is more subtle and nuanced than the word "myeloma" suggests.
Jul 21, 2026
0
3
Researchers have uncovered a clue to why immune checkpoint inhibitors—cancer therapies that release the immune "brakes" exploited by tumors to evade attack—show limited efficacy in some brain tumors. A KAIST research team ...
Jul 20, 2026
0
15
Although the COVID-19 pandemic has largely subsided, scientists continue to investigate why the virus proved so deadly, causing at least 3 million deaths worldwide, according to the latest estimates by the World Health Organization ...
Jul 20, 2026
0
9
Why do some vaccines protect for a lifetime, while threats like tumors and viruses present such an ongoing challenge? The answer lies in the immune system's memory and how invading pathogens hack the system.
Jul 20, 2026
0
7
We may age at different rates, but none of us escapes aging. A study in mice and human cells by Stanford Medicine researchers pins much of the blame on a particular type of immune cell's increasing inability, with advancing ...
Jul 16, 2026
0
118
Humans cannot fully heal spinal cord injuries. When the spinal cord is damaged, the body's immune system often spirals into chaos. This overwhelming inflammatory response creates permanent scar tissue that stops nerve cells ...
Jul 15, 2026
0
199
Researchers at The University of Texas MD Anderson Cancer Center have created a comprehensive single-cell map of the tumor immune microenvironment in multiple myeloma and its precursor conditions. The study provided insights ...
Jul 15, 2026
0
2
Northwestern Medicine scientists have uncovered a biological mechanism that helps explain why most patients with glioblastoma fail to respond to immunotherapy, according to their study published in Nature Communications.
Jul 13, 2026
0
6
